Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
10.05
-1.40 (-12.23%)
Mar 31, 2025, 1:07 PM EDT - Market open
Dyne Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$47.73
Upside
+374.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +69.15% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $46 | Strong Buy | Reiterates | $46 | +357.71% | Mar 17, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +397.51% | Mar 17, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $50 | Buy | Initiates | $50 | +397.51% | Mar 12, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +397.51% | Mar 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +397.51% | Feb 28, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $53 → $48 | Buy | Maintains | $53 → $48 | +377.61% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $46 | Strong Buy | Maintains | $55 → $46 | +357.71% | Feb 28, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Jan 24, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $45 | Buy | Reiterates | $45 | +347.76% | Jan 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +447.26% | Jan 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +397.51% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +447.26% | Jan 10, 2025 |
| Baird | Baird | Buy Initiates $46 | Buy | Initiates | $46 | +357.71% | Dec 13, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $45 | Buy | Initiates | $45 | +347.76% | Nov 26, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +397.51% | Nov 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.